# Nuclide record opp-caix-indeterminate-renal-mass (opportunity). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/opportunities/opp-caix-indeterminate-renal-mass/>
  a schema:CreativeWork ;
  nuclide:kind "opportunity" ;
  schema:identifier "opp-caix-indeterminate-renal-mass" ;
  schema:name "CAIX imaging of the indeterminate renal mass"@en ;
  schema:alternateName "CA9 imaging"@en, "girentuximab PET"@en ;
  schema:description "Scans find small kidney lumps all the time and cannot tell which are cancer. Up to one in five that are surgically removed turn out to be harmless. A scan that recognises the commonest kidney cancer would spare those operations, and it needs no drug to be useful."@en ;
  schema:url <https://nuclide.cc/opportunities/opp-caix-indeterminate-renal-mass/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/39270701/>, <https://clinicaltrials.gov/study/NCT03849118>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC8426244/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC2797464/> ;
  nuclide:tag "standalone diagnostic", "kidney", "biopsy avoidance" ;
  nuclide:related <https://nuclide.cc/isotopes/zr-89/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/tc-99m/> ;
  nuclide:indications <https://nuclide.cc/indications/rcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/technologies/immuno-pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:targets <https://nuclide.cc/targets/caix/> ;
  nuclide:drugs <https://nuclide.cc/drugs/girentuximab-zr89/>, <https://nuclide.cc/drugs/itm-11/> .